STEALTH BIOTHERAPEUTICS CORP
CIK 0001696396
Revenue (TTM)
$21.09M
FY Dec 2021
Net Income (TTM)
−$52.53M
+8.6% YoY
FY Dec 2021
EPS Diluted (TTM)
—
FY Dec 2021
Gross Margin
—
FY Dec 2021
Operating Margin
-219.6%
FY Dec 2021
Net Margin
-249.1%
FY Dec 2021
Free Cash Flow (TTM)
−$45.04M
FY Dec 2021
Cash
$47.14M
FY Dec 2021
Total Debt
$22.66M
FY Dec 2021
Shares Outstanding
712.13M sh
FY Dec 2021
Revenue & Net Income
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.